Previous 10 | Next 10 |
Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...
Gainers: Jaguar Health (JAGX) +191%.Ocugen (OCGN) +177%.Acasti Pharma (ACST) +88%.Scopus BioPharma (SCPS) +50%.Foresight Autonomous Holdings (FRSX) +35%.Onconova Therapeutics (ONTX) +32%.Evogene (EVGN) +31%.Energous Corporation (WATT) +29%.VivoPower International (VVPR) +26%.Phoenix New Media...
Gainers: Ocugen (OCGN) +263%, Jaguar Health (JAGX) +108%, Acasti Pharma (ACST) +61%, Scopus BioPharma (SCPS) +43%, Ekso Bionics Holdings (EKSO) +21%.Losers: Cellectar Biosciences (CLRB) -31%, CRH Medical (CRHM) -23%, CNS Pharmaceuticals (...
Cellectar Biosciences (CLRB) prices previously announced underwritten public offering of its common stock for gross proceeds of ~$24.5M at a public offering price of $1.35 per share.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, compa...
FLORHAM PARK, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pricing of its previously a...
Cellectar Biosciences (CLRB) intends to offer and sell shares of its common stock in a public offering.Actual size, price or terms of the offering are not yet determined. Concurrently, the Company expects to sell common stock and convertible preferred stock at a public offering price, in a pr...
FLORHAM PARK, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it intends to offer and se...
Looking For Biotech Penny Stocks Right Now? One of the most active sets of penny stocks in 2020 has been biotech stocks. Aside from the obvious push from COVID-19 vaccine candidates, companies are utilizing the increased attention to build upon novel treatment pipelines. Evidenced b...
Are Analysts Right About These Penny Stocks? Whether you’re day trading or investing in penny stocks , everyone wants an edge. Some go to extreme lengths to stay 1 step ahead of the retail market. Whether it’s pouring through pages of filings or actually taking a trip ...
Are These Biotech Penny Stocks On Your Radar This Week? When it comes to finding penny stocks to buy, speculation can fuel momentum. One of the top sectors that play off of this speculation well is biotech. Right now, biotech stocks are some of the hottest in the market. This is...
News, Short Squeeze, Breakout and More Instantly...
Cellectar Biosciences Inc. Company Name:
CLRB Stock Symbol:
NASDAQ Market:
Cellectar Biosciences Inc. Website:
FLORHAM PARK, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host an event on July 24, 202...
Opportunity for Iopofosine Expansion Within Areas of High Unmet Need in Non-Hodgkin’s Lymphoma Establishes Partnership With One of the Largest Cancer Research and Treatment Organizations in the U.S. FLORHAM PARK, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences,...
Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, develop...